Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Behavioral Neurology & Neuropsychiatry
How do you distinguish pseudodementia from early Alzheimer's diease with comorbid depression?
Related Questions
How do you counsel eligible patients on how to decide between lecanemab vs donanemab?
When do you select cholinesterase inhibitors vs NMDA-antagonist medications in patients with moderate Alzheimer’s dementia?
How do you approach the medical evaluation of new onset psychosis in elderly patients?
What is your approach to addressing dementia-related agitation for patients living at home with family?
Do you recommend routine neurosyphilis testing in patients being evaluated for dementia?
What are the best practices for centers interested in providing anti-amyloid therapies for early Alzheimer's to ensure treatment delivery success?
How do you counsel elderly patients who demonstrate mild cognitive impairment but do not meet the criteria for a neurocognitive disorder?
What pharmacological management do you consider for self-injurious behavior in patients with autism spectrum disorder?
How do you approach management of neurocognitive and memory deficits in post concussive syndrome?
Is the p-tau217 plasma test used as a surrogate for amyloid PET scan or CSF testing when considering starting Leqembi in patients with Alzheimer's disease?
